Laboratorios Richmond SACIF

Laboratorios Richmond SACIF Goodwill

The Goodwill of Laboratorios Richmond SACIF (RICH.BA) as of Nov 22, 2026 is 4.16 B ARS. In the previous year, Goodwill was 2.75 B ARS — a change of 51.27% (higher).

Goodwill

4.16 BARS

YoY

51.27%

Last updated:

Goodwill of Laboratorios Richmond SACIF is 2024 4.16 B ARS. Goodwill of Laboratorios Richmond SACIF was 2023 2.75 B ARS. It decreases by 51.27% higher compared to the previous year.

The Laboratorios Richmond SACIF Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2017
144.73 M ARS
Jan 1, 2018
221.01 M ARS
Jan 1, 2019
334.81 M ARS
Jan 1, 2020
550.54 M ARS
Jan 1, 2021
1.03 B ARS
Jan 1, 2022
1.02 B ARS
Jan 1, 2023
2.75 B ARS
Jan 1, 2024
4.16 B ARS
The Laboratorios Richmond SACIF Goodwill history
YEARGoodwillYoY
4.16 BARS+51.27%
2.75 BARS+170.24%
1.02 BARS-1.67%
1.03 BARS+87.94%
550.54 MARS+64.43%
334.81 MARS+51.49%
221.01 MARS+52.70%
144.73 MARS+360.64%
31.42 MARS+0.06%
31.40 MARS+6.08%
29.60 MARS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

Goodwill of Laboratorios Richmond SACIF is 4.16 B ARS in 2024.

Goodwill of Laboratorios Richmond SACIF changed from 2.75 B ARS to 4.16 B ARS, representing a 51.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Goodwill Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's ARS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Laboratorios Richmond SACIF historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF